These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17036259)

  • 1. Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder.
    Huuhka K; Anttila S; Huuhka M; Leinonen E; Rontu R; Mattila K; Lehtimäki T
    Eur Arch Psychiatry Clin Neurosci; 2007 Feb; 257(1):31-5. PubMed ID: 17036259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.
    Bousman CA; Katalinic N; Martin DM; Smith DJ; Ingram A; Dowling N; Ng C; Loo CK
    J ECT; 2015 Jun; 31(2):129-35. PubMed ID: 25148110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Cognitive Outcomes After ECT Depending on BDNF and COMT Polymorphisms.
    Bennett DM; Currie J; Fernie G; Perrin JS; Reid IC
    J ECT; 2016 Dec; 32(4):243-250. PubMed ID: 27191122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF polymorphism rs11030101 is associated with the efficacy of electroconvulsive therapy in treatment-resistant depression.
    Viikki ML; Järventausta K; Leinonen E; Huuhka M; Mononen N; Lehtimäki T; Kampman O
    Psychiatr Genet; 2013 Jun; 23(3):134-6. PubMed ID: 23532066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroconvulsive therapy (ECT) and aerobic exercise training (AET) increased plasma BDNF and ameliorated depressive symptoms in patients suffering from major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2016 May; 76():1-8. PubMed ID: 26859236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.
    Sorri A; Järventausta K; Kampman O; Lehtimäki K; Björkqvist M; Tuohimaa K; Hämäläinen M; Moilanen E; Leinonen E
    Brain Behav; 2018 Nov; 8(11):e01101. PubMed ID: 30273985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
    Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
    Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
    Okazaki M; Tominaga K; Higuchi H; Utagawa I; Nakamura E; Noguchi M; Itaya M; Hashimoto C; Yamaguchi N
    J ECT; 2010 Jun; 26(2):87-90. PubMed ID: 19710622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between the G196A and C270T polymorphism of the brain-derived neurotrophic factor gene and male infertility.
    Li Ch; Zheng L; Sun Y; Wang Ch; Li W; Lu Ch; Zhou X
    Genetika; 2012 Mar; 48(3):405-7. PubMed ID: 22679788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.
    Maffioletti E; Gennarelli M; Gainelli G; Bocchio-Chiavetto L; Bortolomasi M; Minelli A
    J ECT; 2019 Sep; 35(3):189-194. PubMed ID: 30994478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.
    Huuhka K; Kampman O; Anttila S; Huuhka M; Rontu R; Mattila KM; Hurme M; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 May; 437(1):25-8. PubMed ID: 18434012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE polymorphism and response to electroconvulsive therapy in major depression.
    Stewart JA; Kampman O; Huuhka M; Anttila S; Huuhka K; Lehtimäki T; Leinonen E
    Neurosci Lett; 2009 Jul; 458(3):122-5. PubMed ID: 19409959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
    Ryan KM; Dunne R; McLoughlin DM
    Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TPH2 polymorphisms may modify clinical picture in treatment-resistant depression.
    Anttila S; Viikki M; Huuhka K; Huuhka M; Huhtala H; Rontu R; Lehtimäki T; Leinonen E
    Neurosci Lett; 2009 Oct; 464(1):43-6. PubMed ID: 19679166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
    Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
    Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
    J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF serum levels and promoter methylation of BDNF exon I, IV and VI in depressed patients receiving electroconvulsive therapy.
    Kleimann A; Kotsiari A; Sperling W; Gröschl M; Heberlein A; Kahl KG; Hillemacher T; Bleich S; Kornhuber J; Frieling H
    J Neural Transm (Vienna); 2015 Jun; 122(6):925-8. PubMed ID: 25387785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy.
    Piccinni A; Del Debbio A; Medda P; Bianchi C; Roncaglia I; Veltri A; Zanello S; Massimetti E; Origlia N; Domenici L; Marazziti D; Dell'Osso L
    Eur Neuropsychopharmacol; 2009 May; 19(5):349-55. PubMed ID: 19223156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional ECT increases BDNF-levels in patients suffering from major depressive disorders compared to patients treated with citalopram only.
    Haghighi M; Salehi I; Erfani P; Jahangard L; Bajoghli H; Holsboer-Trachsler E; Brand S
    J Psychiatr Res; 2013 Jul; 47(7):908-15. PubMed ID: 23583029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.